Evista
Generic name: Raloxifene
Usage of Evista
Evista affects the cycle of bone formation and breakdown in the body, and reduces loss of bone tissue.
Evista is used to treat or prevent osteoporosis in postmenopausal women. Evista is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer.
Evista is not a cancer medication and will not treat breast cancer.
Evista side effects
Get emergency medical help if you have signs of an allergic reaction to Evista: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
Common Evista side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Evista
This medicine may increase your risk of a blood clot in your leg, your lung, or your eye. You should not take Evista if you have ever had this type of blood clot.
This medicine is for use only in women who can no longer get pregnant. Raloxifene can harm an unborn baby. Do not use if you are pregnant or may become pregnant.
Do not breastfeed while taking Evista.
Raloxifene can increase your risk of a stroke, which can be fatal. Tell your doctor if you have ever had:
To make sure Evista is safe for you, tell your doctor if you have ever had:
How to use Evista
Usual Adult Dose for Osteoporosis:
60 mg orally per day Comments: -For treatment or prevention of osteoporosis, advise patients to add supplemental calcium and/or vitamin D if daily intake is inadequate. -When this drug is used to reduce the risk of invasive breast cancer, the optimum duration of treatment is not known. Uses: -Treatment and prevention of osteoporosis in postmenopausal women. -Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and/or at high risk of invasive breast cancer.
Usual Adult Dose for Prevention of Osteoporosis:
60 mg orally per day Comments: -For treatment or prevention of osteoporosis, advise patients to add supplemental calcium and/or vitamin D if daily intake is inadequate. -When this drug is used to reduce the risk of invasive breast cancer, the optimum duration of treatment is not known. Uses: -Treatment and prevention of osteoporosis in postmenopausal women. -Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and/or at high risk of invasive breast cancer.
Usual Adult Dose for Prevention of Breast Cancer:
60 mg orally per day Comments: -For treatment or prevention of osteoporosis, advise patients to add supplemental calcium and/or vitamin D if daily intake is inadequate. -When this drug is used to reduce the risk of invasive breast cancer, the optimum duration of treatment is not known. Uses: -Treatment and prevention of osteoporosis in postmenopausal women. -Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and/or at high risk of invasive breast cancer.
Warnings
Taking Evista may increase your risk of a blood clot in your leg, your lung, or your eye. You should not take this medicine if you have ever had a blood clot.
Evista can also increase your risk of a stroke, which can be fatal. This risk is highest if you have coronary heart disease or certain risk factors (such as diabetes, smoking, being overweight, having high blood pressure or high cholesterol, or having a family history of coronary artery disease).
Although this medicine is for use only in postmenopausal women, you should not take Evista if you are pregnant or breastfeeding.
What other drugs will affect Evista
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with raloxifene, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions